Utilizing a microfluidic single-cell protein imprinting analysis of the nuclei of individual CTCs from ER+ breast cancer patients, Sinkala et al. found that a subset of tumor marker-positive cells also expressed CD45+, indicating the presence of up to 35% of tumor-associated leukocyte subpopulations [178]. Here, ESR1 is linked to neoplasm.